SkyQuest Technology Group recently introduced Biobanking Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Biobanking Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Biobanking Market size was valued at USD 72.0 billion in 2023 and is poised to grow from USD 76.9 billion in 2024 to USD 130.16 billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).
Biobanking has grown tremendously over the years and is currently gaining momentum. The combination of advanced technology, data analytics and automation has transformed traditional biobanks into virtual biobanks, creating transformational Biobanking Market potential. Globally, there are many types of biobanks such as, disease-related biobanks, human-based biobanks quantitatively, tissue banks, blood banks which support the market. The spreading degenerative diseases are benefiting immensely from the growth of this market.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/biobanking-market
The 2025 global Biobanking Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Biobanking Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Biobanking Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Biobanking Market is segmented by Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user and region. Based on Product &Service, the market is segmented into Equipment, Consumables, Services and Software. Based on Biobanks Type, the market is segmented into Physical/Real Biobanks, Tissue Biobanks, Population Based Biobanks, Genetic (DNA/RNA), Disease Based Biobanks and Virtual Biobanks. Based on Sample Type, the market is segmented into Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids and Human Waste Products. Based on Storage Type, the market is segmented into Manual Storage and Automated Storage. Based on Ownership, the market is segmented into Universities, National/Regional Agencies, Non-Profit Organizations and Private Organizations. Based on Application, the market is segmented into Regenerative Medicine, Life Science Research and Clinical Research. Based on End user, the market is segmented into Pharmaceutical, Biotechnology Companies and CROs, Academic, Research Institutes and Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Biobanking Market – Regional Analysis:
– Biobanking North America Market includes (Canada, Mexico, USA)
– Biobanking Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Biobanking Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Biobanking South America Market includes (Brazil, Argentina)
– Biobanking Oceania Market (Australia & New Zealand)
Top Market Players in Biobanking Market are:
Thermo Fisher Scientific Inc. (United States)
Merck KGaA (Germany)
QIAGEN N.V. (Netherlands)
Hamilton Company (United States)
Tecan Trading AG (Switzerland)
Becton, Dickinson and Company (BD) (United States)
Lonza Group AG (Switzerland)
Charles River Laboratories International, Inc. (United States)
BioLife Solutions, Inc. (United States)
Brooks Automation, Inc. (United States)
Greiner Bio-One International GmbH (Austria)
STEMCELL Technologies Inc. (Canada)
Chart Industries, Inc. (United States)
BioIVT (United States)
Firalis S.A. (France)
Celltex Therapeutics Corporation (United States)
Sigma-Aldrich Corporation (United States)
Hope Biosciences (United States)
54Gene (Nigeria)
Take Action Now: Secure Your Biobanking Market Today – https://www.skyquestt.com/buy-now/biobanking-market
FAQ
– What challenges and constraints are affecting the market?
– What geographical variables are influencing the Biobanking market?
– How does the Value Chain concept offer insights into market dynamics?
– Which country dominates the market?
– Which is the leading formulation type for Biobanking Market?
Forward-Looking Insights
The Biobanking Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
